Literature for peptidase S09.003: dipeptidyl-peptidase IV (eukaryote)

(References are filtered for relevance to Target. To remove the filter click here. See explanation.)

2018
1. Ohnuma,K., Hatano,R., Komiya,E., Otsuka,H., Itoh,T., Iwao,N., Kaneko,Y., Yamada,T., Dang,N.H. and Morimoto,C.
   A novel role for CD26/dipeptidyl peptidase IV as a therapeutic target
   Front Biosci (Landmark Ed)23, 1754-1779. PubMed  Europe PubMed  T
2017
2. Akoumianakis,I. and Antoniades,C.
   Dipeptidyl peptidase IV inhibitors as novel regulators of vascular disease
   Vascul Pharmacol96-98, 1-4. PubMed  Europe PubMed DOI  T
2008
3. Lu,I.L., Tsai,K.C., Chiang,Y.K., Jiaang,W.T., Wu,S.H., Mahindroo,N., Chien,C.H., Lee,S.J., Chen,X., Chao,Y.S. and Wu,S.Y.
   A three-dimensional pharmacophore model for dipeptidyl peptidase IV inhibitors
   Eur J Med Chem43, 1603-1611. PubMed  Europe PubMed DOI  T  I
2007
4. Thielitz,A., Reinhold,D., Vetter,R., Bank,U., Helmuth,M., Hartig,R., Wrenger,S., Wiswedel,I., Lendeckel,U., Kahne,T., Neubert,K., Faust,J., Zouboulis,C.C., Ansorge,S. and Gollnick,H.
   Inhibitors of dipeptidyl peptidase IV and aminopeptidase N target major pathogenetic steps in acne initiation
   J Invest Dermatol127, 1042-1051. PubMed  Europe PubMed DOI  T  I
5. Thompson,M.A., Ohnuma,K., Abe,M., Morimoto,C. and Dang,N.H.
   CD26/dipeptidyl peptidase IV as a novel therapeutic target for cancer and immune disorders
   Mini Rev Med Chem7, 253-273. PubMed  Europe PubMed DOI  T
2006
6. Green,B.D., Flatt,P.R. and Bailey,C.J.
   Inhibition of dipeptidylpeptidase IV activity as a therapy of Type 2 diabetes
   Expert Opin Emerg Drugs11, 525-539. PubMed  Europe PubMed DOI  T